Butalbital, Aspirin, And Caffeine 69367-0416-01
- Manufacturer
- Westminster Pharmaceuticals, Llc
- Dosage Form
- Capsule
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CIII
- Marketing Start
- October 24, 2025
- Listing Expires
- December 31, 2027
- Application
- ANDA078149
Active Ingredients
| Ingredient | Strength |
|---|---|
| Aspirin | 325 mg/1 |
| Butalbital | 50 mg/1 |
| Caffeine | 40 mg/1 |
Drug Class
Nonsteroidal Anti-inflammatory Drug [EPC]Platelet Aggregation Inhibitor [EPC]Barbiturate [EPC]
Selected Package
69367-0416-01Selected100 CAPSULE in 1 BOTTLE (69367-416-01)